BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15754010)

  • 1. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L; Biesová Z; Pastoreková S; Kettmann R; Pastorek J
    Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma.
    Ashida S; Nishimori I; Tanimura M; Onishi S; Shuin T
    J Cancer Res Clin Oncol; 2002 Oct; 128(10):561-8. PubMed ID: 12384800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation.
    Duivenvoorden WC; Hopmans SN; Gallino D; Farrell T; Gerdes C; Glennie D; Lukka H; Pinthus JH
    Oncol Rep; 2015 Oct; 34(4):1968-76. PubMed ID: 26252502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma.
    Grabmaier K; A de Weijert MC; Verhaegh GW; Schalken JA; Oosterwijk E
    Oncogene; 2004 Jul; 23(33):5624-31. PubMed ID: 15184875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX.
    Kopacek J; Barathova M; Dequiedt F; Sepelakova J; Kettmann R; Pastorek J; Pastorekova S
    Biochim Biophys Acta; 2005 May; 1729(1):41-9. PubMed ID: 15833446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase.
    Kaluz S; Kaluzová M; Chrastina A; Olive PL; Pastoreková S; Pastorek J; Lerman MI; Stanbridge EJ
    Cancer Res; 2002 Aug; 62(15):4469-77. PubMed ID: 12154057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MN/CA IX antigen as a potential target for renal cell carcinoma].
    Uemura H; Cho M; Nakagawa Y; Shimizu K; Yoshikawa M; Kim S; Hirao Y
    Hinyokika Kiyo; 2000 Oct; 46(10):745-8. PubMed ID: 11215204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma].
    Nakagawa Y; Uemura H; Shimizu K; Cho M; Yoshikawa M; Hirao Y; Yoshikawa K
    Hinyokika Kiyo; 2001 Nov; 47(11):809-14. PubMed ID: 11771176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential for tissue restrictive gene therapy in renal cell carcinoma using MN/CA IX promoter.
    Ou YC; Gardner TA; Kao C; Zhau HE; Chung LW
    Anticancer Res; 2005; 25(2A):881-6. PubMed ID: 15868923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the MN/CA9 gene is associated with hypomethylation in human renal cell carcinoma cell lines.
    Cho M; Grabmaier K; Kitahori Y; Hiasa Y; Nakagawa Y; Uemura H; Hirao Y; Ohnishi T; Yoshikawa K; Ooesterwijk E
    Mol Carcinog; 2000 Mar; 27(3):184-9. PubMed ID: 10708480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer.
    Kaluz S; Kaluzová M; Stanbridge EJ
    Cancer Res; 2003 Mar; 63(5):917-22. PubMed ID: 12615703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
    Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
    Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.
    Nakamura J; Kitajima Y; Kai K; Hashiguchi K; Hiraki M; Noshiro H; Miyazaki K
    Am J Pathol; 2011 Feb; 178(2):515-24. PubMed ID: 21281785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1.
    Takacova M; Holotnakova T; Barathova M; Pastorekova S; Kopacek J; Pastorek J
    Oncol Rep; 2010 Mar; 23(3):869-74. PubMed ID: 20127031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J; Li G; Gentil-Perret A; Gigante M
    Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of carbonic anhydrase 9 at the invasion front of gastric cancers.
    Chen J; Röcken C; Hoffmann J; Krüger S; Lendeckel U; Rocco A; Pastorekova S; Malfertheiner P; Ebert MP
    Gut; 2005 Jul; 54(7):920-7. PubMed ID: 15951534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of in vitro conditions modulating expression of MN/CA IX protein in human cell lines derived from cervical carcinoma.
    Lieskovská J; Opavský R; Záciková L; Glasová M; Pastorek J; Pastoreková S
    Neoplasma; 1999; 46(1):17-24. PubMed ID: 10355529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.
    Said HM; Staab A; Hagemann C; Vince GH; Katzer A; Flentje M; Vordermark D
    J Neurooncol; 2007 Jan; 81(1):27-38. PubMed ID: 16944313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.
    Lim HY; Ahn M; Chung HC; Gardner TA; Kao C; Lee SJ; Kim SJ
    Cancer Gene Ther; 2004 Aug; 11(8):532-8. PubMed ID: 15167900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.